Matches in Nanopublications for { ?s ?p "Consistent with our prediction, IL-4 pretreatment decreases both basal and RANKL-stimulated mRNA levels of Ikappa Balpha , ICAM-1, and TLR-2 (Fig. 7B), all of which are transcriptionally activated by NF-kappa B (28-30)." ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- _4 value "Consistent with our prediction, IL-4 pretreatment decreases both basal and RANKL-stimulated mRNA levels of Ikappa Balpha , ICAM-1, and TLR-2 (Fig. 7B), all of which are transcriptionally activated by NF-kappa B (28-30)." provenance.
- _4 value "Consistent with our prediction, IL-4 pretreatment decreases both basal and RANKL-stimulated mRNA levels of Ikappa Balpha , ICAM-1, and TLR-2 (Fig. 7B), all of which are transcriptionally activated by NF-kappa B (28-30)." provenance.
- _4 value "Consistent with our prediction, IL-4 pretreatment decreases both basal and RANKL-stimulated mRNA levels of Ikappa Balpha , ICAM-1, and TLR-2 (Fig. 7B), all of which are transcriptionally activated by NF-kappa B (28-30)." provenance.
- _4 value "Consistent with our prediction, IL-4 pretreatment decreases both basal and RANKL-stimulated mRNA levels of Ikappa Balpha , ICAM-1, and TLR-2 (Fig. 7B), all of which are transcriptionally activated by NF-kappa B (28-30)." provenance.
- _4 value "Consistent with our prediction, IL-4 pretreatment decreases both basal and RANKL-stimulated mRNA levels of Ikappa Balpha , ICAM-1, and TLR-2 (Fig. 7B), all of which are transcriptionally activated by NF-kappa B (28-30)." provenance.
- _4 value "Consistent with our prediction, IL-4 pretreatment decreases both basal and RANKL-stimulated mRNA levels of Ikappa Balpha , ICAM-1, and TLR-2 (Fig. 7B), all of which are transcriptionally activated by NF-kappa B (28-30)." provenance.
- _4 value "Consistent with our prediction, IL-4 pretreatment decreases both basal and RANKL-stimulated mRNA levels of Ikappa Balpha , ICAM-1, and TLR-2 (Fig. 7B), all of which are transcriptionally activated by NF-kappa B (28-30)." provenance.
- _4 value "Consistent with our prediction, IL-4 pretreatment decreases both basal and RANKL-stimulated mRNA levels of Ikappa Balpha , ICAM-1, and TLR-2 (Fig. 7B), all of which are transcriptionally activated by NF-kappa B (28-30)." provenance.